Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Case Report

Blue nails in chronic myeloid leukemia – Is it usual?

Jaydeep Raj Damor, Jaya Chakravarty, Madhukar Rai, Manaswi Chaubey, Priyanka Kumari, Akash Rai, Ashish Anand Pushpakar, Praveen Kumar Chaturvedi.

Nail toxicity is an uncommon cutaneous adverse effect of imatinib mesylate. Here, we have described a 45-year-old female, a diagnosed case of Philadelphia positive chronic myeloid leukemia, who was on imatinib mesylate for the past 3 months and developed bluish discoloration of the nails. This discoloration was related to the drug imatinib mesylate because the patient was only on imatinib and thyroxine medication. No any other skin-related diseases was present, which can lead to her nail changes.

Key words: Bluish Nail; Imatinib; Chronic Myeloid Leukemia

Similar Articles

Dendritic spine density changes and homeostatic synaptic scaling: a meta-analysis of animal studies.
Moulin TC, Rayêe D, Schiöth HB
Neural regeneration research. 2022; 17(1): 20-24

Effects of electroacupuncture on pain sensation in a rat model of hyperalgesia with nicotine dependence.
Wang SJ, Zhang YP, Candiotti KA
Neural regeneration research. 2022; 17(4): 905-910

Stroke recovery enhancing therapies: lessons from recent clinical trials.
Rogalewski A, Schäbitz WR
Neural regeneration research. 2022; 17(4): 717-720

Exploration of the mechanism by which icariin modulates hippocampal neurogenesis in a rat model of depression.
Zeng NX, Li HZ, Wang HZ, Liu KG, Gong XY, Luo WL, Yan C, Wu LL
Neural regeneration research. 2022; 17(3): 632-642

Time-to-enrollment in clinical trials investigating neurological recovery in chronic spinal cord injury: observations from a systematic review and ClinicalTrials.gov database.
Moinuddin FM, Yolcu YU, Wahood W, Zreik J, Goncalves S, Windebank AJ, Qu W, Bydon M
Neural regeneration research. 2022; 17(5): 953-958

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.

ScopeMed Web Sites